Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-IL-8 murine monoclonal antibody cream for scalp psoriasis
ChiCTR2100054119Phase 4Not yet recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Nov 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mouse anti-human interleukin-8 monoclonal antibody in psoriasis and plaque psoriasis (2 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Scalp Psoriasis Severity Index score. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
mouse anti-human interleukin-8 monoclonal antibody
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on ChiCTR2100054119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054119.